PUMA BIOTECHNOLOGY, INC. (PBYI) Form 10-K Annual Reports
PUMA BIOTECHNOLOGY, INC. (PBYI) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: PBYI
CIK: 1401667
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2017 12:00:00 AM
Lead Engagement PartnerFranklin Wimer III
Audit LocationLos Angeles, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13D/A | 2026-10-06 | — | SCHEDULE 13D/A Filing | 0001104659-26-114167 | View SEC Doc Filr Page |
| 4 | 2026-09-16 | 2026-09-14 | FORM 4 | 0001437749-26-030597 | View SEC Doc Filr Page |
| 4 | 2026-09-16 | 2026-09-14 | FORM 4 | 0001437749-26-030593 | View SEC Doc Filr Page |
| 144 | 2026-09-14 | — | 144 Filing | 0001959173-26-006918 | View SEC Doc Filr Page |
| 144 | 2026-09-14 | — | 144 Filing | 0001959173-26-006917 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | FORM 10-Q | 0001437749-26-026311 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | FORM 8-K | 0001437749-26-026282 | View SEC Doc Filr Page |
| 4 | 2026-07-08 | 2026-07-06 | FORM 4 | 0001437749-26-023079 | View SEC Doc Filr Page |
| 4 | 2026-07-08 | 2026-07-06 | FORM 4 | 0001437749-26-023078 | View SEC Doc Filr Page |
| 4 | 2026-07-08 | 2026-07-06 | FORM 4 | 0001437749-26-023077 | View SEC Doc Filr Page |
| 144 | 2026-07-06 | — | 144 Filing | 0001959173-26-005126 | View SEC Doc Filr Page |
| 144 | 2026-07-06 | — | 144 Filing | 0001959173-26-005123 | View SEC Doc Filr Page |
| 144 | 2026-07-06 | — | 144 Filing | 0001959173-26-005121 | View SEC Doc Filr Page |
| 8-K | 2026-06-16 | 2026-06-11 | FORM 8-K | 0001437749-26-020793 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | FORM 4 | 0001437749-26-020709 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | FORM 4 | 0001437749-26-020708 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | FORM 4 | 0001437749-26-020706 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | FORM 4 | 0001437749-26-020705 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | FORM 4 | 0001437749-26-020704 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | FORM 4 | 0001437749-26-020703 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | FORM 4 | 0001437749-26-020702 | View SEC Doc Filr Page |
| 144 | 2026-06-12 | — | 144 Filing | 0001959173-26-004590 | View SEC Doc Filr Page |
| 144 | 2026-06-12 | — | 144 Filing | 0001959173-26-004589 | View SEC Doc Filr Page |
| 144 | 2026-06-12 | — | 144 Filing | 0001959173-26-004588 | View SEC Doc Filr Page |
| 144 | 2026-06-12 | — | 144 Filing | 0001959173-26-004586 | View SEC Doc Filr Page |